These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36865958)

  • 1. Anti-CV2/Collapsin Response Mediator Protein 5 (CRMP5) Paraneoplastic Encephalitis Induced by Small Cell Lung Cancer.
    Helgason VÞ; Qureshi PAAA; Bollineni VR; Þórarinsson BL; Arkink EB
    Cureus; 2023 Jan; 15(1):e34323. PubMed ID: 36865958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
    Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
    Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent.
    Ibrahim Ismail I; K John J; Ibrahim M; Al-Hashel JY
    Case Rep Neurol; 2020; 12(1):50-55. PubMed ID: 32110228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
    Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.
    Yan J; Chen Z; Liang Y; Yang H; Cao L; Zhou Y; Zhao Y; Zhang Y
    J Int Med Res; 2020 Dec; 48(12):300060520974466. PubMed ID: 33305627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
    Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
    Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.
    Martin L; Stratton HJ; Gomez K; Le Duy D; Loya-Lopez S; Tang C; Calderon-Rivera A; Ran D; Nunna V; Bellampalli SS; François-Moutal L; Dumaire N; Salih L; Luo S; Porreca F; Ibrahim M; Rogemond V; Honnorat J; Khanna R; Moutal A
    bioRxiv; 2024 May; ():. PubMed ID: 38766071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report.
    Aydin D; Somnier F; Lassen LH
    Case Rep Neurol; 2016; 8(1):16-9. PubMed ID: 26889151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
    Juárez-Vignon Whaley JJ; Carrera-Muiños A; Hernandez-Gutierrez KG; Rodriguez-Cid JR; Otero-Cerdeira ME; Garcia-Montes V
    Case Rep Oncol; 2021; 14(3):1799-1805. PubMed ID: 35111012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
    Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
    BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
    Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
    Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
    Fu P; He L; Tang N; Nie Q; Li Z
    J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
    Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
    Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report.
    Liu B; Zhou L; Zheng Y; Sun C; Lin J
    Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
    Sato C; Kano T; Yabe I; Sasaki H
    Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.
    Li H; Zhang A; Hao Y; Guan H; Lv Z
    Medicine (Baltimore); 2018 May; 97(19):e0696. PubMed ID: 29742721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in the detection of CV2 (CRMP5) antibodies.
    Sabater L; Saiz A; Dalmau J; Graus F
    J Neuroimmunol; 2016 Jan; 290():80-3. PubMed ID: 26711575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine.
    Ha J; Na BS; Ahn JH; Kim M; Kim JW; Lee JH; Cho JW; Kim JS; Youn J
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.